Jose Bardelas
Allergy & Immunology · High Point, NCNPI 1265490841
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Optinose US, Inc. at 40.8% of the total. Reporting peaked in 2019 at $5,007 and has fallen 86.2% since, to $692 in 2023.
Across 198 payments — averaging $50.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- LEO Pharma Inc.$2K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$654
- Sanofi$346
- Alk-abello, Inc$234
- plus $2K from 22 others
Across 47 payments — averaging $2087.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- LEO Pharma AS$57K
- Astrazeneca AB$22K
- Sanofi US Services Inc.$11K
- Regeneron$9K
- Merck$104
What the payments were for
- Consulting fees$4,30043%
- Travel & lodging$98510%
- Food & beverage$4,64847%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 36 | $4,049 |
| LEO Pharma Inc. | 1 | $1,800 |
| AstraZeneca | 39 | $1,005 |
| Regeneron Healthcare Solutions, Inc. | 24 | $654 |
| Sanofi | 14 | $346 |
| Alk-abello, Inc | 4 | $234 |
| Novartis | 12 | $219 |
| Merck | 2 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $154 |
| Genentech USA, Inc. | 2 | $153 |
| GSK | 6 | $139 |
| Kaleo, Inc. | 9 | $122 |
| Shire North American Group Inc | 2 | $108 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| CSL Behring | 2 | $90 |
| Regeneron | 3 | $89 |
| Aytu Biopharma, Inc. | 5 | $82 |
| Mylan Specialty L.p. | 4 | $75 |
| Pfizer | 4 | $63 |
| Boehringer Ingelheim | 3 | $59 |
| Biocryst US Sales Co., LLC | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Covis Pharma GmbH | 3 | $37 |
| Grifols USA, LLC | 2 | $31 |
| Incyte Corporation | 1 | $22 |
| Octapharma USA, Inc. | 1 | $18 |
| Hospira, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,933 in reported general payments places this provider in the 65th percentile of 140 allergy & immunology providers in North Carolina.
Other allergy & immunology in High Point
- Evelyn LomasneyHigh Point$8K
- Maeve OconnorCharlotte$2.2M
- Joel HartmanWinston Salem$749K
- Cristine RadojicicDurham$558K
- Scott ComminsChapel Hill$555K
- William McCannAsheville$486K
- Aerik WilliamsSalisbury$298K
- Karen DunnRaleigh$258K
- Roopen PatelCharlotte$257K
- Jonathan RomeoRaleigh$230K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.